Hyperpnea in Orthostatic Intolerance
Hyperpnea in Orthostatic Intolerance
批准号:
7433672
负责人:
JULIAN M STEWART
金额:
$23.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2010-03-31
关键词:
AffectAgeAmericanBaroreflexBlood CirculationBlood flowBreathingCarbon DioxideCarotid BodyCerebral HypoxiaCerebrovascular CirculationCerebrumChemoreceptorsChronic Orthostatic IntoleranceDataDizzinessEmploymentEnrollmentEnvironmental air flowEventExhibitsFatigueFunctional disorderGenderHeartHeart RateHyperpneaHyperventilationHypocapniaInvestigationLeftLungMeasuresMethodsMuscleNerveOxygenPatientsPeripheralRateRelative (related person)ResearchRespirationSchoolsStressStretchingSymptomsSyndromeSystemTachycardiaTestingUltrasonographyWomanbaseelectric impedanceperipheral bloodpreventprospectiveresearch studyrespiratoryresponsestretch reflexvasoconstrictionvolunteer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic orthostatic intolerance takes the form of postural tachycardia syndrome (POTS) in many patients. POTS pathophysiology is heterogeneous but frequently related to increased sympathetic activation and often accompanied by hyperpnea without tachypnea. Cerebral blood flow is reduced by hypocapnia and systemic vasoregulation is also detrimentally affected. We hypothesize that excessive baroreflex unloading during orthostatic stress is the initiating event in POTS resulting in 1) reduced inhibition of chemoreceptor activity centrally and 2) stimulation of peripheral chemoreceptor activity due to sympathetically induced reductions in blood flow to the carotid body. Increased chemoreceptor activity leads to hyperpnea. We will test this hypothesis by comparing POTS patients with orthostatic hyperpnea (N=20) and without orthostatic hyperpnea (N=20), to healthy control subjects (N=15) asking the following research questions: 1) Is the respiratory chemoreflex function abnormal in POTS with hyperpnea and does it affect ventilation, sympathetic activity and baroreflex function differently compared to control subjects? 2) Does baroreflex unloading produce excessive sympathetic and chemoreflex activity, and pulmonary stretch response in POTS patients with hyperpnea compared to POTS patients without hyperpnea and to control subjects? 3) Does sympathetic stimulation unrelated to the baroreflexes affect chemoreflex sensitivity and sympathetic nerve activity in POTS? : To answer these questions we will enroll 40 subjects and 20 age and gender matched control subjects. Experiments will test whether hyperpnea is caused by sympathoexcitation initiated by baroreflex unloading, potentiated by chemoreflexes, and modulated by pulmonary stretch reflexes. Chemoreflex function curves for ventilation and muscle sympathetic nerve activity (MSNA, obtained by peroneal microneurography) will be measured during controlled changes in inhaled CO2 and oxygen. Interactive effects of chemoreceptors on baroreflexes, and baroreflexes on chemoreflexes will be assessed using MSNA, continuous BP assessment, pneumotachography, and measures of central blood flow using impedance methods, and ultrasound. The modified Oxford method will be used to intermittently assess the cardiovagal and sympathetic baroreflex, and will be supplemented by wavelet based continuous assessment of heart rate, BP, MSNA and peripheral blood flow. Hyperpnea and reduced cerebral blood flow is a severely debilitating and poorly tolerated finding in POTS. Prospective data will define the pathophysiological mechanisms involved in hyperpneic POTS in order to develop specific and effective therapy for the illness. Project Narrative Chronic orthostatic intolerance due to the postural tachycardia syndrome (POTS) affects over a million Americans, mostly young women, who are prevented from gainful employ or school attendance. While a rapid heart rate (tachycardia) is the hallmark of the illness, patients often develop hyperventilation and respiratory difficulty which remain unexplained. In the current proposal we will perform sophisticated tests of the circulation and respiration systems to study the causes, mechanisms and potential treatments of upright hyperventilation in POTS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovagal baroreflex deficits impair neurovascular coupling and cognition in Postural Tachycardia Syndrome
-
批准号:9358891
-
项目类别:
-
资助金额:$62.65万
-
财政年份:2017
-
负责人:JULIAN M STEWART
-
依托单位:
Mechanisms of Vasovagal Syncope
-
批准号:8793208
-
项目类别:
-
资助金额:$52.43万
-
财政年份:2013
-
负责人:JULIAN M STEWART
-
依托单位:
Mechanisms of Vasovagal Syncope
-
批准号:8418978
-
项目类别:
-
资助金额:$54.11万
-
财政年份:2013
-
负责人:JULIAN M STEWART
-
依托单位:
Mechanisms of Vasovagal Syncope
-
批准号:8996697
-
项目类别:
-
资助金额:$53.23万
-
财政年份:2013
-
负责人:JULIAN M STEWART
-
依托单位:
Mechanisms of Vasovagal Syncope
-
批准号:8606885
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2013
-
负责人:JULIAN M STEWART
-
依托单位:
Vascular Dysfunction in CFS
-
批准号:7790653
-
项目类别:
-
资助金额:$39.75万
-
财政年份:2008
-
负责人:JULIAN M STEWART
-
依托单位:
Hyperpnea in Orthostatic Intolerance
-
批准号:7590461
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2008
-
负责人:JULIAN M STEWART
-
依托单位:
Vascular Dysfunction in CFS
-
批准号:7364034
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2008
-
负责人:JULIAN M STEWART
-
依托单位:
Vascular Dysfunction in CFS
-
批准号:7597133
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2008
-
负责人:JULIAN M STEWART
-
依托单位:
Detecting Endothelial Dysfunction in Renal Failure
-
批准号:7230178
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2006
-
负责人:JULIAN M STEWART
-
依托单位:
Detecting Endothelial Dysfunction in Renal Failure
-
批准号:7090411
-
项目类别:
-
资助金额:$23.41万
-
财政年份:2006
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:7089833
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:7906372
-
项目类别:
-
资助金额:$40.63万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:8103920
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:6820293
-
项目类别:
-
资助金额:$36.76万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:7448458
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:8293198
-
项目类别:
-
资助金额:$38.21万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:8490407
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:6910779
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
Local Vasoconstriction in Postural Tachycardia Syndrome
-
批准号:7239569
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2004
-
负责人:JULIAN M STEWART
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: